| 2024 | Adjuvant Chemotherapy after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma with Variant Histology: A Systematic Review and Meta-Analysis of Survival Outcomes | UROLOGIA INTERNATIONALIS |
| 2024 | Impact of family history of prostate cancer on disease progression for prostatic cancer patients undergoing active surveillance: A systematic review and meta-analysis | INVESTIGATIVE AND CLINICAL UROLOGY |
| 2024 | Androgen Deprivation Therapy and Newly Developed Neovascular Age-Related Macular Degeneration Risk in Patients with Prostate Cancer | JOURNAL OF CLINICAL MEDICINE |
| 2023 | Differences in clinical features between focal and extensive types of cystitis glandularis in patients without a previous history of urinary tract malignancy | Investigative and Clinical Urology |
| 2023 | Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis | Investigative and Clinical Urology |
| 2022 | Intravesical Recurrence after Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma Is Associated with Flexible Diagnostic Ureteroscopy, but Not with Rigid Diagnostic Ureteroscopy | Cancers |
| 2022 | Relationship between Androgen Deprivation Therapy and Normal-Tension Glaucoma in Patients with Prostate Cancer: A Nationwide Cohort Study | Yonsei Medical Journal |
| 2022 | Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but not with Vascular Dementia | The World Journal of Men's Health |
| 2022 | Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study | Urologic Oncology: Seminars and Original Investigations |
| 2021 | Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study | Prostate International |
| 2021 | Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer | BIOMEDICINES |
| 2021 | Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis | CANCERS |
| 2021 | Androgen-deprivation therapy and the risk of newly developed fractures in patients with prostate cancer: a nationwide cohort study in Korea | SCIENTIFIC REPORTS |
| 2021 | Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Seasonal variations in overactive bladder drug prescription rates in women: a nationwide population-based study | World Journal of Urology |
| 2020 | Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012-2016 | INTERNATIONAL NEUROUROLOGY JOURNAL(대한배뇨장애요실금학회지) |
| 2019 | Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratio | WORLD JOURNAL OF UROLOGY |
| 2018 | Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate Cancer | JOURNAL OF UROLOGY |
http://orcid.org/0000-0002-3923-4619
